Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension
Article in Biomedicine & Pharmacotherapy (April 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (April 2024)
Article in Journal of Cellular Physiology (March 2024)
Preprint in Research Square (December 2023)